United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast
Pediatric Vaccines market for United States is a multi-billion dollar industry. The value of United States pediatric vaccines market alone is expected to reach more than US$ 18 Billion by 2020. The United States Pediatric vaccines market is driven by favorable demographics, growing public acceptance and product innovation. Varicella and Pneumococcal vaccines (PCV) control the highest and second highest market share in United States respectively. Together both of these vaccines control more than 50% market share.
In number of cases Polio, MMR, Diphtheria and Tetanus cases have diminished significantly from the year 2001 till 2013. In United States, DTP are the highly penetrated vaccines in pediatric vaccines market which contributed more than 100 Million doses in 2014. Polio and MMR are also mostly used vaccines together they consumed more than 150 Million doses in 2014. It is predicted that these three vaccines will bolster the usable pattern in the United States.
The United States pediatric vaccines are expected to remain highly active in the future, fueled by the encouragement and financing from Governments and other health organizations.
This is 8th edition report on Vaccines Market & 3rd edition on Pediatric Vaccines Market by Renub Research. Report titled " United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast” talks about the pediatric vaccines. The report provides information on all the Ten (10) Pediatric Vaccines Market, Doses, Number of Children Being Vaccinated and Number of Cases in United States. This report covers in detail all aspects of past, present and future scenario. The report also entails major factors driving the Pediatric vaccines market and challenges of Pediatric vaccines market.
Ten (10) Pediatric Vaccines Covered in this Report are as follows:
1. Measles, Mumps & Rubella (MMR) Vaccines
2. Haemophilus Influenzae Type B (HIB) Vaccines
3. Polio Vaccines
4. Diphtheria Tetanus & Pertussis (DTaP) Vaccines
5. Pneumococcal Vaccines
6. Rotavirus Vaccines
7. Hepatitis B Pediatric Vaccines
8. Hepatitis A Pediatric Vaccines
9. Varicella / Chicken Pox Vaccines
10. Influenza Pediatric Vaccines
All the Pediatric Vaccines in this Report have been studied from Four View Points:
1. Number of Cases
2. Number of Doses
3. Number of Children Being Vaccinated
4. Market Size for all 10 Pediatric Vaccines
Key Topics Covered in the Report
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
In number of cases Polio, MMR, Diphtheria and Tetanus cases have diminished significantly from the year 2001 till 2013. In United States, DTP are the highly penetrated vaccines in pediatric vaccines market which contributed more than 100 Million doses in 2014. Polio and MMR are also mostly used vaccines together they consumed more than 150 Million doses in 2014. It is predicted that these three vaccines will bolster the usable pattern in the United States.
The United States pediatric vaccines are expected to remain highly active in the future, fueled by the encouragement and financing from Governments and other health organizations.
This is 8th edition report on Vaccines Market & 3rd edition on Pediatric Vaccines Market by Renub Research. Report titled " United States Pediatric Vaccines Market, Doses, Immunization (Vaccinated), Cases & Forecast” talks about the pediatric vaccines. The report provides information on all the Ten (10) Pediatric Vaccines Market, Doses, Number of Children Being Vaccinated and Number of Cases in United States. This report covers in detail all aspects of past, present and future scenario. The report also entails major factors driving the Pediatric vaccines market and challenges of Pediatric vaccines market.
Ten (10) Pediatric Vaccines Covered in this Report are as follows:
1. Measles, Mumps & Rubella (MMR) Vaccines
2. Haemophilus Influenzae Type B (HIB) Vaccines
3. Polio Vaccines
4. Diphtheria Tetanus & Pertussis (DTaP) Vaccines
5. Pneumococcal Vaccines
6. Rotavirus Vaccines
7. Hepatitis B Pediatric Vaccines
8. Hepatitis A Pediatric Vaccines
9. Varicella / Chicken Pox Vaccines
10. Influenza Pediatric Vaccines
All the Pediatric Vaccines in this Report have been studied from Four View Points:
1. Number of Cases
2. Number of Doses
3. Number of Children Being Vaccinated
4. Market Size for all 10 Pediatric Vaccines
Key Topics Covered in the Report
- United States – Pediatric Vaccines Market & Forecast
- United States – Pediatric Vaccines Market Share & Forecast
- United States - Pediatric Disease Cases
- Pediatric Vaccines Doses and Forecast
- Number of Children Being Vaccinated
- Market Size for all 10 Pediatric Vaccines
- Growth Drivers of Pediatric Vaccines Market
- Challenges of Pediatric Vaccines Market
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
1. EXECUTIVE SUMMARY
2. UNITED STATES – PEDIATRIC VACCINES MARKET & FORECAST
3. UNITED STATES – PEDIATRIC VACCINES MARKET SHARE & FORECAST
4. UNITED STATES – PEDIATRIC VACCINES CASES, DOSES, IMMUNIZATION COVERAGE, MARKET & FORECAST
4.1 United States – Measles, Mumps & Rubella (MMR) Vaccines & Forecast
4.1.1 Number of Measles, Mumps & Rubella (MMR) Cases
4.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses
4.1.3 Measles, Mumps & Rubella (MMR) – Number of Children Being Vaccinated
4.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines
4.2 United States – Haemophilus Influenzae Type B (HIB) Vaccines & Forecast
4.2.1 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses
4.2.2 Haemophilus Influenzae Type B (HIB) – Number of Children Being Vaccinated
4.2.3 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines
4.3 United States – Polio Vaccines & Forecast
4.3.1 Number of Polio Cases
4.3.2 Number of Polio Vaccines Doses
4.3.3 Polio Vaccines – Number of Children Being Vaccinated
4.3.4 Market Size of Polio Vaccines
4.4 United States – Diphtheria, Tetanus & Pertussis (DTap) Vaccines & Forecast
4.4.1 Number of Diphtheria, Tetanus & Pertussis (DTaP) Cases
4.4.2 Number of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Doses
4.4.3 Diphtheria, Tetanus & Pertusis (DTaP) – Number of Children Being Vaccinated
4.4.4 Market Size of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines
4.5 United States – Pneumococcal Vaccines & Forecast
4.5.1 Number of Pneumococcal Vaccines Doses
4.5.2 Pneumococcal – Number of Children Being Vaccinated
4.5.3 Market Size of Pneumococcal Vaccines
4.6 United States – Rotavirus Vaccines & Forecast
4.6.1 Number of Rotavirus Vaccines Doses
4.6.2 Rotavirus – Number of Children Being Vaccinated
4.6.3 Market Size of Rotavirus Vaccine
4.7 United States – Hepatitis B Pediatric Vaccines & Forecast
4.7.1 Number of Hepatitis B Pediatric Vaccines Doses
4.7.2 Hepatitis B Pediatric – Number of Children Being Vaccinated
4.7.3 Market Size of Hepatitis B Pediatric Vaccines
4.8 United States – Hepatitis A Pediatric Vaccines & Forecast
4.8.1 Number of Hepatitis A Pediatric Vaccines Doses
4.8.2 Hepatitis A Pediatric – Number of Children Being Vaccinated & Forecast
4.8.3 Market Size of Hepatitis A Pediatric Vaccines
4.9 United States – Varicella / Chicken Pox Vaccines & Forecast
4.9.1 Number of Varicella / Chicken Pox Vaccines Doses
4.9.2 Varicella/Chicken Pox – Number of Children Being Vaccinated
4.9.3 Market Size of Varicella/Chicken Pox Vaccines
4.10 United States – Influenza Pediatric Vaccines & Forecast
4.10.1 Number of Influenza Pediatric Vaccines Doses
4.10.2 Influenza Pediatric Vaccines – Number of Children Being Vaccinated
4.10.3 Market Size of Influenza Pediatric Vaccines
5. GROWTH DRIVERS OF UNITED STATES PEDIATRIC VACCINES MARKET
5.1 Increase Immunization Rates & Reduce Preventable Infectious Diseases
5.2 Increasing Vaccine Availability in United States
5.3 The Vaccine Safety Data link Project
5.4 The Vaccine Injury Compensation Program
5.5 Transforming of Vaccine Technologies
5.6 Continuous Focus on Effective Communication Strategies
6. CHALLENGES OF UNITED STATES PEDIATRIC VACCINES MARKET
6.1 Impediment in Pediatric Vaccine Research & Development
6.2 Barriers to New Entrants in the Pediatric Vaccines Market
6.3 Hurdles to Optimal use of Licensed Vaccines
6.3.1 Technical Obstacles
6.3.2 Economic obstacles
6.3.3 Cultural Obstacles
6.4 Complexity of Vaccine Development & Approval System Thwarts Product Development
6.4.1 Legal Obstacles
6.4.2 General Technical Barriers
6.4.3 Economic Barriers
6.4.4 Regulatory Barriers
6.5 Shortening the Timeline for Vaccine Development
6.6 Refusal / Resistance to Vaccination
6.6.1 Vaccine Adverse Event Reporting System
6.7 Vaccine Shortages and Delays
6.8 Emerging Issues in Immunization and Infectious Diseases in United States
2. UNITED STATES – PEDIATRIC VACCINES MARKET & FORECAST
3. UNITED STATES – PEDIATRIC VACCINES MARKET SHARE & FORECAST
4. UNITED STATES – PEDIATRIC VACCINES CASES, DOSES, IMMUNIZATION COVERAGE, MARKET & FORECAST
4.1 United States – Measles, Mumps & Rubella (MMR) Vaccines & Forecast
4.1.1 Number of Measles, Mumps & Rubella (MMR) Cases
4.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses
4.1.3 Measles, Mumps & Rubella (MMR) – Number of Children Being Vaccinated
4.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines
4.2 United States – Haemophilus Influenzae Type B (HIB) Vaccines & Forecast
4.2.1 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses
4.2.2 Haemophilus Influenzae Type B (HIB) – Number of Children Being Vaccinated
4.2.3 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines
4.3 United States – Polio Vaccines & Forecast
4.3.1 Number of Polio Cases
4.3.2 Number of Polio Vaccines Doses
4.3.3 Polio Vaccines – Number of Children Being Vaccinated
4.3.4 Market Size of Polio Vaccines
4.4 United States – Diphtheria, Tetanus & Pertussis (DTap) Vaccines & Forecast
4.4.1 Number of Diphtheria, Tetanus & Pertussis (DTaP) Cases
4.4.2 Number of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Doses
4.4.3 Diphtheria, Tetanus & Pertusis (DTaP) – Number of Children Being Vaccinated
4.4.4 Market Size of Diphtheria, Tetanus & Pertussis (DTaP) Vaccines
4.5 United States – Pneumococcal Vaccines & Forecast
4.5.1 Number of Pneumococcal Vaccines Doses
4.5.2 Pneumococcal – Number of Children Being Vaccinated
4.5.3 Market Size of Pneumococcal Vaccines
4.6 United States – Rotavirus Vaccines & Forecast
4.6.1 Number of Rotavirus Vaccines Doses
4.6.2 Rotavirus – Number of Children Being Vaccinated
4.6.3 Market Size of Rotavirus Vaccine
4.7 United States – Hepatitis B Pediatric Vaccines & Forecast
4.7.1 Number of Hepatitis B Pediatric Vaccines Doses
4.7.2 Hepatitis B Pediatric – Number of Children Being Vaccinated
4.7.3 Market Size of Hepatitis B Pediatric Vaccines
4.8 United States – Hepatitis A Pediatric Vaccines & Forecast
4.8.1 Number of Hepatitis A Pediatric Vaccines Doses
4.8.2 Hepatitis A Pediatric – Number of Children Being Vaccinated & Forecast
4.8.3 Market Size of Hepatitis A Pediatric Vaccines
4.9 United States – Varicella / Chicken Pox Vaccines & Forecast
4.9.1 Number of Varicella / Chicken Pox Vaccines Doses
4.9.2 Varicella/Chicken Pox – Number of Children Being Vaccinated
4.9.3 Market Size of Varicella/Chicken Pox Vaccines
4.10 United States – Influenza Pediatric Vaccines & Forecast
4.10.1 Number of Influenza Pediatric Vaccines Doses
4.10.2 Influenza Pediatric Vaccines – Number of Children Being Vaccinated
4.10.3 Market Size of Influenza Pediatric Vaccines
5. GROWTH DRIVERS OF UNITED STATES PEDIATRIC VACCINES MARKET
5.1 Increase Immunization Rates & Reduce Preventable Infectious Diseases
5.2 Increasing Vaccine Availability in United States
5.3 The Vaccine Safety Data link Project
5.4 The Vaccine Injury Compensation Program
5.5 Transforming of Vaccine Technologies
5.6 Continuous Focus on Effective Communication Strategies
6. CHALLENGES OF UNITED STATES PEDIATRIC VACCINES MARKET
6.1 Impediment in Pediatric Vaccine Research & Development
6.2 Barriers to New Entrants in the Pediatric Vaccines Market
6.3 Hurdles to Optimal use of Licensed Vaccines
6.3.1 Technical Obstacles
6.3.2 Economic obstacles
6.3.3 Cultural Obstacles
6.4 Complexity of Vaccine Development & Approval System Thwarts Product Development
6.4.1 Legal Obstacles
6.4.2 General Technical Barriers
6.4.3 Economic Barriers
6.4.4 Regulatory Barriers
6.5 Shortening the Timeline for Vaccine Development
6.6 Refusal / Resistance to Vaccination
6.6.1 Vaccine Adverse Event Reporting System
6.7 Vaccine Shortages and Delays
6.8 Emerging Issues in Immunization and Infectious Diseases in United States
LIST OF FIGURES
Figure 2 1: United States – Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 2 2: United States – Forecast for Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 3 1: United States – Pediatric Vaccines Market Share (Percent), 2010 – 2014
Figure 3 2: United States – Forecast for Pediatric Vaccines Market Share (Percent), 2015 – 2020
Figure 4 1: United States – Number of MMR Vaccines Doses (Million Doses), 2010 – 2014
Figure 4 2: United States – Forecast for Number of MMR Vaccines Doses (Million Doses), 2015 – 2020.
Figure 4 3: United States – Number of Children Being Vaccinated with MMR Vaccines (Million), 2010 – 2014
Figure 4 4: United States – Forecast for Number of Children Being Vaccinated with MMR Vaccines (Million), 2015 – 2020
Figure 4 5: United States – Measles, Mumps & Rubella Vaccines Market (Million US$), 2010 – 2014
Figure 4 6: United States – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2015 – 2020
Figure 4 7: United States – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2010 – 2014
Figure 4 8: United States – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2015 – 2020
Figure 4 9: United States – Number of Children Being Vaccinated with Haemophilus Influenzae Type B Vaccines (Million), 2010 – 2014
Figure 4 10: United States – Number of Children Being Vaccinated with Haemophilus Influenzae Type B Vaccines (Million), 2015 – 2020
Figure 4 11: United States – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2010 – 2014
Figure 4 12: United States – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2015 – 2020
Figure 4 14: United States – Number of Doses of Polio Vaccines (Million Doses), 2010 – 2014
Figure 4 15: United States – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2015 – 2020
Figure 4 16: United States – Number of Children Being Vaccinated with Polio Vaccines (Million), 2010 – 2014
Figure 4 17: United States – Forecast for Number of Children Being Vaccinated with Polio Vaccines (Million), 2015 – 2020
Figure 4 18: United States – Polio Vaccines Market (Million US$), 2010 – 2014
Figure 4 19: United States – Forecast for Polio Vaccines Market (Million US$), 2015 – 2020
Figure 4 20: United States – Number of Doses of DTaP Vaccines (Million Doses), 2010 – 2014
Figure 4 21: United States – Forecast for Number of Doses of DTaP Vaccines (Million Doses), 2015 – 2020
Figure 4 22: United States – Number of Children Being Vaccinated with DTaP Vaccines (Million), 2010 – 2014
Figure 4 23: United States – Forecast for Number of Children Being Vaccinated with DTaP Vaccines (Million), 2015 – 2020
Figure 4 24: United States – Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2010 – 2014
Figure 4 25: United States – Forecast for Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2015 – 2020
Figure 4 26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025
Figure 4 27: United States – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2014
Figure 4 28: United States – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2015 – 2020
Figure 4 29: United States – Number of Children Being Vaccinated with Pneumococcal Vaccines (Million), 2010 – 2014
Figure 4 30: United States – Forecast for Number of Children Being Vaccinated with Pneumococcal Vaccines (Million), 2015 – 2020
Figure 4 31: United States – Pneumococcal Vaccines Market (Million US$), 2010 – 2014
Figure 4 32: United States – Forecast for Pneumococcal Vaccines Market (Million US$), 2015 – 2020
Figure 4 33: United States – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2014
Figure 4 34: United States – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2015 – 2020
Figure 4 35: United States – Number of Children Being Vaccinated with Rotavirus Vaccines (Million), 2010 – 2014
Figure 4 36: United States – Forecast for Number of Children Being Vaccinated with Rotavirus Vaccines (Million), 2015 – 2020
Figure 4 37: United States – Rotavirus Vaccines Market (Million US$), 2010 – 2014
Figure 4 38: United States – Forecast for Rotavirus Vaccines Market (Million US$), 2015 – 2020
Figure 4 39: United States – Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2010 – 2014
Figure 4 40: United States – Forecast for Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2015 – 2020
Figure 4 41: United States – Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines (Million), 2010 – 2014
Figure 4 42: United States – Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines (Million), 2015 – 2020
Figure 4 43: United States – Hepatitis B Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 4 44: United States – Forecast for Hepatitis B Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 4 45: United States – Number of Doses of Hepatitis A Pediatric Vaccines (Million Doses), 2010 – 2014
Figure 4 46: United States – Forecast for Number of Doses of Hepatitis A Pediatric Vaccines (Million Doses), 2015 – 2020
Figure 4 47: United States – Number of Children Being Vaccinated with Hepatitis A Pediatric Vaccines (Million), 2010 – 2014
Figure 4 48: United States – Forecast for Number of Children Being Vaccinated with Hepatitis A Pediatric Vaccines (Million), 2015 – 2020
Figure 4 49: United States – Hepatitis A Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 4 50: United States – Forecast for Hepatitis A Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 4 51: United States – Number of Doses of Varicella Vaccines (Million Doses), 2010 – 2014
Figure 4 52: United States – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2015 – 2020
Figure 4 53: United States – Number of Children Being Vaccinated with Varicella Vaccines (Million), 2010 – 2014
Figure 4 54: United States – Forecast for Number of Children Being Vaccinated with Varicella Vaccines (Million), 2015 – 2020
Figure 4 55: United States – Varicella Vaccines Market (Million US$), 2010 – 2014
Figure 4 56: United States – Forecast for Varicella Vaccines Market (Million US$), 2015 – 2020
Figure 4 57: United States – Number of Influenza Pediatric Vaccines Doses (Million Doses), 2010 – 2014
Figure 4 58: United States – Forecast for Number of Influenza Pediatric Vaccines Doses (Million Doses), 2015 – 2020
Figure 4 59: United States – Number of Children Being Vaccinated with Influenza Pediatric Vaccines (Million), 2010 – 2014
Figure 4 60: United States – Forecast for Number of Children Being Vaccinated with Influenza Pediatric Vaccines (Million), 2015 – 2020
Figure 4 61: United States – Influenza Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 4 62: United States – Forecast for Influenza Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 5 1: United States – Number of Retail Clinics offering Vaccination (Number), 2007 – 2012
Figure 2 1: United States – Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 2 2: United States – Forecast for Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 3 1: United States – Pediatric Vaccines Market Share (Percent), 2010 – 2014
Figure 3 2: United States – Forecast for Pediatric Vaccines Market Share (Percent), 2015 – 2020
Figure 4 1: United States – Number of MMR Vaccines Doses (Million Doses), 2010 – 2014
Figure 4 2: United States – Forecast for Number of MMR Vaccines Doses (Million Doses), 2015 – 2020.
Figure 4 3: United States – Number of Children Being Vaccinated with MMR Vaccines (Million), 2010 – 2014
Figure 4 4: United States – Forecast for Number of Children Being Vaccinated with MMR Vaccines (Million), 2015 – 2020
Figure 4 5: United States – Measles, Mumps & Rubella Vaccines Market (Million US$), 2010 – 2014
Figure 4 6: United States – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2015 – 2020
Figure 4 7: United States – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2010 – 2014
Figure 4 8: United States – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2015 – 2020
Figure 4 9: United States – Number of Children Being Vaccinated with Haemophilus Influenzae Type B Vaccines (Million), 2010 – 2014
Figure 4 10: United States – Number of Children Being Vaccinated with Haemophilus Influenzae Type B Vaccines (Million), 2015 – 2020
Figure 4 11: United States – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2010 – 2014
Figure 4 12: United States – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2015 – 2020
Figure 4 14: United States – Number of Doses of Polio Vaccines (Million Doses), 2010 – 2014
Figure 4 15: United States – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2015 – 2020
Figure 4 16: United States – Number of Children Being Vaccinated with Polio Vaccines (Million), 2010 – 2014
Figure 4 17: United States – Forecast for Number of Children Being Vaccinated with Polio Vaccines (Million), 2015 – 2020
Figure 4 18: United States – Polio Vaccines Market (Million US$), 2010 – 2014
Figure 4 19: United States – Forecast for Polio Vaccines Market (Million US$), 2015 – 2020
Figure 4 20: United States – Number of Doses of DTaP Vaccines (Million Doses), 2010 – 2014
Figure 4 21: United States – Forecast for Number of Doses of DTaP Vaccines (Million Doses), 2015 – 2020
Figure 4 22: United States – Number of Children Being Vaccinated with DTaP Vaccines (Million), 2010 – 2014
Figure 4 23: United States – Forecast for Number of Children Being Vaccinated with DTaP Vaccines (Million), 2015 – 2020
Figure 4 24: United States – Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2010 – 2014
Figure 4 25: United States – Forecast for Diphtheria, Tetanus & Pertussis (DTaP) Vaccines Market (Million US$), 2015 – 2020
Figure 4 26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025
Figure 4 27: United States – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2014
Figure 4 28: United States – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2015 – 2020
Figure 4 29: United States – Number of Children Being Vaccinated with Pneumococcal Vaccines (Million), 2010 – 2014
Figure 4 30: United States – Forecast for Number of Children Being Vaccinated with Pneumococcal Vaccines (Million), 2015 – 2020
Figure 4 31: United States – Pneumococcal Vaccines Market (Million US$), 2010 – 2014
Figure 4 32: United States – Forecast for Pneumococcal Vaccines Market (Million US$), 2015 – 2020
Figure 4 33: United States – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2014
Figure 4 34: United States – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2015 – 2020
Figure 4 35: United States – Number of Children Being Vaccinated with Rotavirus Vaccines (Million), 2010 – 2014
Figure 4 36: United States – Forecast for Number of Children Being Vaccinated with Rotavirus Vaccines (Million), 2015 – 2020
Figure 4 37: United States – Rotavirus Vaccines Market (Million US$), 2010 – 2014
Figure 4 38: United States – Forecast for Rotavirus Vaccines Market (Million US$), 2015 – 2020
Figure 4 39: United States – Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2010 – 2014
Figure 4 40: United States – Forecast for Number of Doses of Hepatitis B Pediatric Vaccines (Million Doses), 2015 – 2020
Figure 4 41: United States – Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines (Million), 2010 – 2014
Figure 4 42: United States – Number of Children Being Vaccinated with Hepatitis B Pediatric Vaccines (Million), 2015 – 2020
Figure 4 43: United States – Hepatitis B Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 4 44: United States – Forecast for Hepatitis B Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 4 45: United States – Number of Doses of Hepatitis A Pediatric Vaccines (Million Doses), 2010 – 2014
Figure 4 46: United States – Forecast for Number of Doses of Hepatitis A Pediatric Vaccines (Million Doses), 2015 – 2020
Figure 4 47: United States – Number of Children Being Vaccinated with Hepatitis A Pediatric Vaccines (Million), 2010 – 2014
Figure 4 48: United States – Forecast for Number of Children Being Vaccinated with Hepatitis A Pediatric Vaccines (Million), 2015 – 2020
Figure 4 49: United States – Hepatitis A Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 4 50: United States – Forecast for Hepatitis A Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 4 51: United States – Number of Doses of Varicella Vaccines (Million Doses), 2010 – 2014
Figure 4 52: United States – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2015 – 2020
Figure 4 53: United States – Number of Children Being Vaccinated with Varicella Vaccines (Million), 2010 – 2014
Figure 4 54: United States – Forecast for Number of Children Being Vaccinated with Varicella Vaccines (Million), 2015 – 2020
Figure 4 55: United States – Varicella Vaccines Market (Million US$), 2010 – 2014
Figure 4 56: United States – Forecast for Varicella Vaccines Market (Million US$), 2015 – 2020
Figure 4 57: United States – Number of Influenza Pediatric Vaccines Doses (Million Doses), 2010 – 2014
Figure 4 58: United States – Forecast for Number of Influenza Pediatric Vaccines Doses (Million Doses), 2015 – 2020
Figure 4 59: United States – Number of Children Being Vaccinated with Influenza Pediatric Vaccines (Million), 2010 – 2014
Figure 4 60: United States – Forecast for Number of Children Being Vaccinated with Influenza Pediatric Vaccines (Million), 2015 – 2020
Figure 4 61: United States – Influenza Pediatric Vaccines Market (Million US$), 2010 – 2014
Figure 4 62: United States – Forecast for Influenza Pediatric Vaccines Market (Million US$), 2015 – 2020
Figure 5 1: United States – Number of Retail Clinics offering Vaccination (Number), 2007 – 2012
LIST OF TABLES
Table 4 1: United States – Number of Measles Cases (Number), 1999 – 2013
Table 4 2: United States – Number of Mumps Cases (Number), 1999 – 2013
Table 4 3: United States – Number of Rubella Cases (Number), 1999 – 2013
Table 4 4: United States – Number of Polio Cases (Number), 2001 – 2013
Table 4 5: United States – Number of Diphtheria Cases (Number), 1999 – 2013
Table 4 6: United States – Number of nTetanus Cases (Number), 1999 – 2013
Table 4 7: United States – Number of tTetanus Cases (Number), 1999 – 2013
Table 4 8: United States – Number of Pertussis Cases (Number), 1999 – 2013
Table 5 1: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations
Table 4 1: United States – Number of Measles Cases (Number), 1999 – 2013
Table 4 2: United States – Number of Mumps Cases (Number), 1999 – 2013
Table 4 3: United States – Number of Rubella Cases (Number), 1999 – 2013
Table 4 4: United States – Number of Polio Cases (Number), 2001 – 2013
Table 4 5: United States – Number of Diphtheria Cases (Number), 1999 – 2013
Table 4 6: United States – Number of nTetanus Cases (Number), 1999 – 2013
Table 4 7: United States – Number of tTetanus Cases (Number), 1999 – 2013
Table 4 8: United States – Number of Pertussis Cases (Number), 1999 – 2013
Table 5 1: Improvement Strategies or Requirements – the Joint Commission and the Project’s Collaborating Organizations
